These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29197465)

  • 21. CD44 and its role in inflammation and inflammatory diseases.
    Johnson P; Ruffell B
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):208-20. PubMed ID: 19601881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted kill: from umbrellas to monoclonal antibodies.
    Byers VS; Baldwin RW
    J Clin Immunol; 1992 Nov; 12(6):391-405. PubMed ID: 1287032
    [No Abstract]   [Full Text] [Related]  

  • 23. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.
    Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A
    Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics.
    Melis JP; Strumane K; Ruuls SR; Beurskens FJ; Schuurman J; Parren PW
    Mol Immunol; 2015 Oct; 67(2 Pt A):117-30. PubMed ID: 25697848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticytokine therapy in autoimmune diseases.
    Nishimoto N; Kishimoto T; Yoshizaki K
    Intern Med; 1999 Feb; 38(2):178-82. PubMed ID: 10225680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.
    Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC
    Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokines, inflammation, and autoimmune diseases.
    Ward PA
    Hosp Pract (1995); 1995 May; 30(5):35-41. PubMed ID: 7744979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory aspects of new medicines targeted at treatment of autoimmune diseases.
    Hull KM; Yim S
    Clin Pharmacol Ther; 2012 Apr; 91(4):739-42. PubMed ID: 22398965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Kaveri SV; Mouthon L; Kazatchkine MD
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):6-8. PubMed ID: 7964857
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine MD; Kaveri SV
    N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745
    [No Abstract]   [Full Text] [Related]  

  • 31. Future perspectives of therapeutic monoclonal antibodies.
    Tsumoto K; Isozaki Y; Yagami H; Tomita M
    Immunotherapy; 2019 Feb; 11(2):119-127. PubMed ID: 30730271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current status of monoclonal antibodies in autoimmune diseases and problems associated with their clinical application].
    Horiuchi A
    Nihon Rinsho; 1983; 41(4):830-3. PubMed ID: 6350652
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in targeted therapies 2017.
    Breedveld FC; Kalden JR; Smolen JS
    Clin Immunol; 2018 Jan; 186():1-2. PubMed ID: 29378299
    [No Abstract]   [Full Text] [Related]  

  • 34. T cell subtypes and its therapeutic potential in autoimmune diseases and cancer.
    Awasthi A; Kumar H
    Int Rev Immunol; 2019; 38(5):181-182. PubMed ID: 31608783
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibodies in the breakdown lane.
    Blumberg RS; Lencer WI
    Nat Biotechnol; 2005 Oct; 23(10):1232-4. PubMed ID: 16211062
    [No Abstract]   [Full Text] [Related]  

  • 36. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis.
    Joyce-Shaikh B; Bigler ME; Chao CC; Murphy EE; Blumenschein WM; Adamopoulos IE; Heyworth PG; Antonenko S; Bowman EP; McClanahan TK; Phillips JH; Cua DJ
    J Exp Med; 2010 Mar; 207(3):579-89. PubMed ID: 20212065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmunity: present-day concepts and future prospects.
    Hong R
    Curr Probl Pediatr; 1991 Jul; 21(6):253-8. PubMed ID: 1914513
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases.
    Bayry J
    Immunotherapy; 2012 Jan; 4(1):9-12. PubMed ID: 22149994
    [No Abstract]   [Full Text] [Related]  

  • 39. -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?
    Ballow M
    J Allergy Clin Immunol; 2005 Oct; 116(4):738-43. PubMed ID: 16210044
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting TNF and its family members in autoimmune/inflammatory disease.
    Desplat-Jégo S; Burkly L; Putterman C
    Mediators Inflamm; 2014; 2014():628748. PubMed ID: 24803741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.